Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Rohto Pharmaceutical CoRPHCF 89 Interest Coverage is 20.34 as of Mar. 2026, which is 85% below its 10-year median of 135.51. GuruFocus rates RPHCF with a GF Score™ of 89/100 and a GF Value™ of $21.04. The stock has 2 warning signs investors should review. Among 1,514 Consumer Packaged Goods companies, Rohto Pharmaceutical Co ranks better than 71.8% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Rohto Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was $48 Mil. Rohto Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was $-2 Mil.
Rohto Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 20.34.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Rohto Pharmaceutical Co's Interest Coverage or its related term are showing as below:
RPHCF'
s Interest Coverage Range Over the Past 10 Years
Min: 32.03 Med: 135.51 Max: 204.35
Current: 32.03
RPHCF's Interest Coverage is ranked better than 71.8% of 1514
companies
in the Consumer Packaged Goods industry
Industry Median: 8.605
vs RPHCF: 32.03
Rohto Pharmaceutical Co (OTCPK:RPHCF) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Rohto Pharmaceutical Co Interest Coverage Related Terms
Rohto Pharmaceutical Co Interest Coverage Historical Data
* Premium members only.
The historical data trend for Rohto Pharmaceutical Co's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
RPHCF vs PG, CL, KVUE: Interest Coverage Comparison
For the Household & Personal Products subindustry, Rohto Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rohto Pharmaceutical Co Interest Coverage vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Rohto Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Rohto Pharmaceutical Co's Interest Coverage falls into.
Rohto Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rohto Pharmaceutical Co (RPHCF) has a Interest Coverage of 20.34 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Rohto Pharmaceutical Co and its competitors. This is 85% below median its historical median of 135.51. Over the past decade, Rohto Pharmaceutical Co's Interest Coverage has ranged from 32.03 to 204.35. According to the industry distribution chart, Rohto Pharmaceutical Co ranks #427 out of 1514 companies in the Consumer Packaged Goods industry, placing it in the top 28.2%.
Is Rohto Pharmaceutical Co's Interest Coverage too high?
Rohto Pharmaceutical Co's current Interest Coverage of 20.34 is 85% below median its 10-year median of 135.51. Over the past 10 years, this metric has ranged from a low of 32.03 to a high of 204.35. The Consumer Packaged Goods industry median Interest Coverage is 8.61. Rohto Pharmaceutical Co's value of 20.34 is 136.4% above this industry median. Based on the distribution chart, Rohto Pharmaceutical Co ranks #427 out of 1514 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Rohto Pharmaceutical Co has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Rohto Pharmaceutical Co's Interest Coverage compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Rohto Pharmaceutical Co ranks #427 out of 1514 companies for Interest Coverage. This puts Rohto Pharmaceutical Co in the upper half of its industry. The industry median Interest Coverage is 8.61. Rohto Pharmaceutical Co's value of 20.34 is 136.4% above this benchmark. Historically, Rohto Pharmaceutical Co's own Interest Coverage has ranged from 32.03 to 204.35 over the past decade. While the company's 10-year median is 135.51 vs. the industry median of 8.61, Rohto Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Consumer Packaged Goods company?
The median Interest Coverage among Consumer Packaged Goods companies is 8.61, based on 1,514 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Rohto Pharmaceutical Co's current Interest Coverage of 20.34 is 136.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Rohto Pharmaceutical Co and its competitors. For the Consumer Packaged Goods industry, the median Interest Coverage is 8.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Rohto Pharmaceutical Co's current Interest Coverage is 20.34, which is 85% below median its own 10-year median of 135.51. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rohto Pharmaceutical Co stock overvalued right now?
Rohto Pharmaceutical Co (RPHCF) has a current Interest Coverage of 20.34. The stock's GF Value™ is $21.04, compared to a current price of $15.00 — trading 28.7% below its estimated fair value. The current Interest Coverage is 20.34, which is 85% below median its 10-year median of 135.51 and 136.4% above the Consumer Packaged Goods industry median of 8.61. Rohto Pharmaceutical Co's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Rohto Pharmaceutical Co (RPHCF), the current Interest Coverage is 20.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rohto Pharmaceutical Co (RPHCF) Overvalued in 2026?
Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued.
The current stock price of $15.00 is trading 28.7% below its estimated GF Value™ of $21.04.
Key valuation signals for RPHCF:
Interest Coverage: 20.34 (85% below median its 10-year median of 135.51)
GF Value™: $21.04 vs. price of $15.00 (28.7% below fair value)
Industry Position: 136.4% above the Consumer Packaged Goods median (#427 of 1514)
No single metric tells the full story. See the RPHCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
89GF Score
Get the complete analysis for RPHCF
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RPHCF has been successfully added to your 
